Search
Inmode Ltd
INMDAdd to Watchlist
13.400USD
+0.040+0.30%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
849.01MMarket Cap
9.79P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Inmode Ltd is 6.67, ranking 159 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 16.00, with a high of 21.00 and a low of 15.00.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
14.333
Target Price
+7.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Inmode Ltd
INMD
6
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Inmode Ltd's expected revenue for the next quarter?
Inmode Ltd's expected revenue is 92.65M.
What is Inmode Ltd's price target?
Analysts forecast that Inmode Ltd's price target is USD 16.00, with the highest forecast at USD 21.00 and the lowest forecast at USD 15.00.
How have Inmode LtdINMD's recent earnings per share performed?
The market expectation was USD 0.18, while Inmode LtdINMD's earnings per share (EPS) for the previous quarter was USD 0.43. EPS for the next quarter is expected at USD 0.33.
What is the analyst rating for Inmode Ltd?
Based on the ratings of Inmode Ltd's stock from 6 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
